Abiopharma

New Form 8-K - Y-mAbs Therapeutics, Inc. Filed: 2025-08-05 AccNo: 0001104659-25-073993 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits